Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Capricor Therapeutics, Inc. (CAPR) had Return on Tangible Equity of -16.54% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-40.73M |
|
-- |
|
-- |
|
$42.95M |
|
$-42.95M |
|
$2.21M |
|
$-40.73M |
|
$-40.73M |
|
$-40.73M |
|
$-40.73M |
|
$-40.73M |
|
$-40.73M |
|
$-42.95M |
|
$-43.28M |
|
57.93M |
|
57.93M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$242.13M |
|
$36.35M |
|
$126.61M |
|
$368.74M |
|
$32.96M |
|
-- |
|
$89.56M |
|
$122.52M |
|
$246.22M |
|
$246.22M |
|
$246.22M |
|
58.11M |
|
| Cash Flow Statement Financials | |
$-60.74M |
|
$-203.40M |
|
$-2.77M |
|
$287.85M |
|
$20.94M |
|
$-266.91M |
|
$11.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-77.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.54% |
|
|
Return on Tangible Equity |
-16.54% |
-11.05% |
|
-16.54% |
|
$4.24 |
|
$-1.33 |
|
$-1.05 |
|